IGF1 and breast cancer: Given evidence implicating lipids and IGF-I as potential modifiable risk factors for breast cancer (25–27), there is motivation to assess the bi-directional relationship between circulating lipids and IGF-I and to test the hypothesis that pathways from these phenotypes to breast cancer overlap.